By Hannah Barnett A popular metaphor for futile and repetitive labour comes from Greek mythology, in which Zeus condemns King Sisyphus to eternally roll a massive boulder up a hill, only for it to tumble back down just before reaching the summit. In a new editorial published in the Journal of Psychopharmacology, David Nutt considers whether modern psychopharmacology has fallen into its own Sisyphean cycle through the relentless pursuit of highly specific psychiatric drugs. These drugs target...

In late April, the Donald Trump administration announced plans to reschedule marijuana from a Schedule I to Schedule III substance.

On Saturday, Donald Trump signed an executive order aimed at accelerating clinical research into psychedelic drugs. The order focuses on expanding federal funding, reducing bureaucratic barriers, and speeding up regulatory timelines. The move signals a notable shift in U.S. federal posture toward psychedelics—distinct from ongoing developments at the state level—and arguably represents one of the most significant federal actions on psychedelic research and access to date.